Palatable formulations
US-12544336-B2 · Feb 10, 2026 · US
This page is not indexed by search engines while we improve data quality.
Elanco Us Inc — Cross-Sectional Technologies
Elanco Us Inc holds 6 patents in Cross-Sectional Technologies, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Elanco Us Inc |
| Technology | Cross-Sectional Technologies |
| Patents in slice | 6 |
| Recent patents in slice | 3 |
| First year | 2022 |
| Last year | 2026 |
Representative patents
Notable publications linking Elanco Us Inc to Cross-Sectional Technologies.
Probiotic compositions comprising lactobacillus reuteri strains and methods of use
US-12427174-B2 · Sep 30, 2025 · US
Palatable formulations
US-2023372249-A1 · Nov 23, 2023 · US
A genetically modified lactobacillus and uses thereof
US-2022127628-A1 · Apr 28, 2022 · US
Probiotic compositions comprising lactobacillus reuteri strains and methods of use
US-2022125860-A1 · Apr 28, 2022 · US
Recent filings
Latest patents from Elanco Us Inc in Cross-Sectional Technologies.
Palatable formulations
US-12544336-B2 · Feb 10, 2026 · US
Probiotic compositions comprising lactobacillus reuteri strains and methods of use
US-12427174-B2 · Sep 30, 2025 · US
Palatable formulations
US-2023372249-A1 · Nov 23, 2023 · US
A genetically modified lactobacillus and uses thereof
US-2022127628-A1 · Apr 28, 2022 · US
Probiotic compositions comprising lactobacillus reuteri strains and methods of use
US-2022125860-A1 · Apr 28, 2022 · US
Related pages
Navigate to parent entity pages.